Congenital FXIII Deficiency

Prevalence

0.1 / 100K

0 drugs in development·0 companies·1 clinical trial

Frequently asked questions

How many clinical trials target Congenital FXIII Deficiency?

There are 1 clinical trial targeting Congenital FXIII Deficiency tracked by BioSniper.

What is the prevalence of Congenital FXIII Deficiency?

The estimated prevalence of Congenital FXIII Deficiency is approximately 0.1 per 100,000 population.

Deep-dive into Congenital FXIII Deficiency

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    Congenital FXIII Deficiency — Drugs in Development & Clinical Trials | BioSniper